報告摘要

The global Anti-PD-1 MAb market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032. North America: the Anti-PD-1 MAb market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Anti-PD-1 MAb market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Anti-PD-1 MAb market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Anti-PD-1 MAb include Thermo Fisher Scientific, Merck KGaA, Ximbio, Sino Biological, OriGene Technologies, Leinco Technologies, Elabscience and BioVision, among others; in 2025, the top three vendors together accounted for approximately % of global revenue. Report Scope This report quantifies the global Anti-PD-1 MAb market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032. It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Anti-PD-1 MAb. Key Companies & Market Share Insights This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking. Anti-PD-1 MAb Market by Company Thermo Fisher Scientific Merck KGaA Ximbio Sino Biological OriGene Technologies Leinco Technologies Elabscience BioVision Anti-PD-1 MAb Segment by Type 1mg 2.5mg Others Anti-PD-1 MAb Segment by Application Pharmaceutical Research Other Anti-PD-1 MAb Segment by Region North America United States Canada Europe Germany France U.K. Italy Spain Russia Netherlands Nordic Countries Asia-Pacific China Japan South Korea India Australia China Taiwan Southeast Asia South America Mexico Brazil Argentina Middle East & Africa Saudi Arabia Israel United Arab Emirates Turkey Iran Egypt Key Drivers & Barriers High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects. Reasons to Buy This Report 1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-PD-1 MAb market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market. 2. This report will help stakeholders to understand the global industry status and trends of Anti-PD-1 MAb and provides them with information on key market drivers, restraints, challenges, and opportunities. 3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition. 4. This report stays updated with novel technology integration, features, and the latest developments in the market 5. This report helps stakeholders to gain insights into which regions to target globally 6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-PD-1 MAb. 7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution. Chapter Outline Chapter 1: Research objectives, research methods, data sources, data cross-validation; Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 6: Detailed analysis of Anti-PD-1 MAb companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc. Chapter 13: The main points and conclusions of the report.

目錄 Table of Contents

1 Preface 1.1 Scope of Report 1.2 Reasons for Doing This Study 1.3 Research Methodology 1.4 Research Process 1.5 Data Source 1.5.1 Secondary Sources 1.5.2 Primary Sources 2 Market Overview 2.1 Product Definition 2.2 Anti-PD-1 MAb by Type 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) 2.2.2 1mg 2.2.3 2.5mg 2.2.4 Others 2.3 Anti-PD-1 MAb by Application 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) 2.3.2 Pharmaceutical 2.3.3 Research 2.3.4 Other 2.4 Assumptions and Limitations 3 Anti-PD-1 MAb Breakdown Data by Type 3.1 Global Anti-PD-1 MAb Historic Market Size by Type (2021-2026) 3.2 Global Anti-PD-1 MAb Forecasted Market Size by Type (2027-2032) 4 Anti-PD-1 MAb Breakdown Data by Application 4.1 Global Anti-PD-1 MAb Historic Market Size by Application (2021-2026) 4.2 Global Anti-PD-1 MAb Forecasted Market Size by Application (2027-2032) 5 Global Growth Trends 5.1 Global Anti-PD-1 MAb Market Perspective (2021-2032) 5.2 Global Anti-PD-1 MAb Growth Trends by Region 5.2.1 Global Anti-PD-1 MAb Market Size by Region: 2021 VS 2025 VS 2032 5.2.2 Anti-PD-1 MAb Historic Market Size by Region (2021-2026) 5.2.3 Anti-PD-1 MAb Forecasted Market Size by Region (2027-2032) 5.3 Anti-PD-1 MAb Market Dynamics 5.3.1 Anti-PD-1 MAb Industry Trends 5.3.2 Anti-PD-1 MAb Market Drivers 5.3.3 Anti-PD-1 MAb Market Challenges 5.3.4 Anti-PD-1 MAb Market Restraints 6 Market Competitive Landscape by Players 6.1 Global Top Anti-PD-1 MAb Players by Revenue 6.1.1 Global Top Anti-PD-1 MAb Players by Revenue (2021-2026) 6.1.2 Global Anti-PD-1 MAb Revenue Market Share by Players (2021-2026) 6.2 Global Anti-PD-1 MAb Industry Players Ranking, 2023 VS 2024 VS 2025 6.3 Global Key Players of Anti-PD-1 MAb Head Office and Area Served 6.4 Global Anti-PD-1 MAb Players, Product Type & Application 6.5 Global Anti-PD-1 MAb Manufacturers Established Date 6.6 Global Anti-PD-1 MAb Market CR5 and HHI 6.7 Global Players Mergers & Acquisition 7 North America 7.1 North America Anti-PD-1 MAb Market Size (2021-2032) 7.2 North America Anti-PD-1 MAb Market Growth Rate by Country: 2021 VS 2025 VS 2032 7.3 North America Anti-PD-1 MAb Market Size by Country (2021-2026) 7.4 North America Anti-PD-1 MAb Market Size by Country (2027-2032) 7.5 United States 7.5 United States 7.6 Canada 7.7 Mexico 8 Europe 8.1 Europe Anti-PD-1 MAb Market Size (2021-2032) 8.2 Europe Anti-PD-1 MAb Market Growth Rate by Country: 2021 VS 2025 VS 2032 8.3 Europe Anti-PD-1 MAb Market Size by Country (2021-2026) 8.4 Europe Anti-PD-1 MAb Market Size by Country (2027-2032) 8.5 Germany 8.6 France 8.7 U.K. 8.8 Italy 8.9 Spain 8.10 Russia 8.11 Netherlands 8.12 Nordic Countries 9 Asia-Pacific 9.1 Asia-Pacific Anti-PD-1 MAb Market Size (2021-2032) 9.2 Asia-Pacific Anti-PD-1 MAb Market Growth Rate by Country: 2021 VS 2025 VS 2032 9.3 Asia-Pacific Anti-PD-1 MAb Market Size by Country (2021-2026) 9.4 Asia-Pacific Anti-PD-1 MAb Market Size by Country (2027-2032) 9.5 China 9.6 Japan 9.7 South Korea 9.8 India 9.9 Australia 9.10 China Taiwan 9.11 Southeast Asia 10 South America 10.1 South America Anti-PD-1 MAb Market Size (2021-2032) 10.2 South America Anti-PD-1 MAb Market Growth Rate by Country: 2021 VS 2025 VS 2032 10.3 South America Anti-PD-1 MAb Market Size by Country (2021-2026) 10.4 South America Anti-PD-1 MAb Market Size by Country (2027-2032) 10.5 Brazil 10.6 Argentina 10.7 Chile 10.8 Colombia 10.9 Peru 11 Middle East & Africa 11.1 Middle East & Africa Anti-PD-1 MAb Market Size (2021-2032) 11.2 Middle East & Africa Anti-PD-1 MAb Market Growth Rate by Country: 2021 VS 2025 VS 2032 11.3 Middle East & Africa Anti-PD-1 MAb Market Size by Country (2021-2026) 11.4 Middle East & Africa Anti-PD-1 MAb Market Size by Country (2027-2032) 11.5 Saudi Arabia 11.6 Israel 11.7 United Arab Emirates 11.8 Turkey 11.9 Iran 11.10 Egypt 12 Players Profiled 12.1 Thermo Fisher Scientific 12.1.1 Thermo Fisher Scientific Company Information 12.1.2 Thermo Fisher Scientific Business Overview 12.1.3 Thermo Fisher Scientific Revenue in Anti-PD-1 MAb Business (2021-2026) 12.1.4 Thermo Fisher Scientific Anti-PD-1 MAb Product Portfolio 12.1.5 Thermo Fisher Scientific Recent Developments 12.2 Merck KGaA 12.2.1 Merck KGaA Company Information 12.2.2 Merck KGaA Business Overview 12.2.3 Merck KGaA Revenue in Anti-PD-1 MAb Business (2021-2026) 12.2.4 Merck KGaA Anti-PD-1 MAb Product Portfolio 12.2.5 Merck KGaA Recent Developments 12.3 Ximbio 12.3.1 Ximbio Company Information 12.3.2 Ximbio Business Overview 12.3.3 Ximbio Revenue in Anti-PD-1 MAb Business (2021-2026) 12.3.4 Ximbio Anti-PD-1 MAb Product Portfolio 12.3.5 Ximbio Recent Developments 12.4 Sino Biological 12.4.1 Sino Biological Company Information 12.4.2 Sino Biological Business Overview 12.4.3 Sino Biological Revenue in Anti-PD-1 MAb Business (2021-2026) 12.4.4 Sino Biological Anti-PD-1 MAb Product Portfolio 12.4.5 Sino Biological Recent Developments 12.5 OriGene Technologies 12.5.1 OriGene Technologies Company Information 12.5.2 OriGene Technologies Business Overview 12.5.3 OriGene Technologies Revenue in Anti-PD-1 MAb Business (2021-2026) 12.5.4 OriGene Technologies Anti-PD-1 MAb Product Portfolio 12.5.5 OriGene Technologies Recent Developments 12.6 Leinco Technologies 12.6.1 Leinco Technologies Company Information 12.6.2 Leinco Technologies Business Overview 12.6.3 Leinco Technologies Revenue in Anti-PD-1 MAb Business (2021-2026) 12.6.4 Leinco Technologies Anti-PD-1 MAb Product Portfolio 12.6.5 Leinco Technologies Recent Developments 12.7 Elabscience 12.7.1 Elabscience Company Information 12.7.2 Elabscience Business Overview 12.7.3 Elabscience Revenue in Anti-PD-1 MAb Business (2021-2026) 12.7.4 Elabscience Anti-PD-1 MAb Product Portfolio 12.7.5 Elabscience Recent Developments 12.8 BioVision 12.8.1 BioVision Company Information 12.8.2 BioVision Business Overview 12.8.3 BioVision Revenue in Anti-PD-1 MAb Business (2021-2026) 12.8.4 BioVision Anti-PD-1 MAb Product Portfolio 12.8.5 BioVision Recent Developments 13 Report Conclusion 14 Disclaimer

圖表清單 List of Tables & Figures

List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Anti-PD-1 MAb Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Anti-PD-1 MAb Revenue Market Share by Type (2021-2026) Table 7. Global Anti-PD-1 MAb Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Anti-PD-1 MAb Revenue Market Share by Type (2027-2032) Table 9. Global Anti-PD-1 MAb Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Anti-PD-1 MAb Revenue Market Share by Application (2021-2026) Table 11. Global Anti-PD-1 MAb Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Anti-PD-1 MAb Revenue Market Share by Application (2027-2032) Table 13. Global Anti-PD-1 MAb Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Anti-PD-1 MAb Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Anti-PD-1 MAb Market Share by Region (2021-2026) Table 16. Global Anti-PD-1 MAb Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Anti-PD-1 MAb Market Share by Region (2027-2032) Table 18. Anti-PD-1 MAb Industry Trends Table 19. Anti-PD-1 MAb Industry Drivers Table 20. Anti-PD-1 MAb Industry Opportunities and Challenges Table 21. Anti-PD-1 MAb Market Restraints Table 22. Global Top Anti-PD-1 MAb Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Anti-PD-1 MAb Revenue Market Share by Players (2021-2026) Table 24. Global Anti-PD-1 MAb Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Anti-PD-1 MAb, Headquarters and Area Served Table 26. Global Anti-PD-1 MAb Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Anti-PD-1 MAb by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Anti-PD-1 MAb Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Anti-PD-1 MAb Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Anti-PD-1 MAb Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Anti-PD-1 MAb Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Anti-PD-1 MAb Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Anti-PD-1 MAb Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Anti-PD-1 MAb Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Anti-PD-1 MAb Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Anti-PD-1 MAb Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Anti-PD-1 MAb Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Anti-PD-1 MAb Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Anti-PD-1 MAb Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Anti-PD-1 MAb Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Anti-PD-1 MAb Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Anti-PD-1 MAb Market Size by Country (2027-2032) & (US$ Million) Table 45. Thermo Fisher Scientific Company Information Table 46. Thermo Fisher Scientific Business Overview Table 47. Thermo Fisher Scientific Revenue in Anti-PD-1 MAb Business (2021-2026) & (US$ Million) Table 48. Thermo Fisher Scientific Anti-PD-1 MAb Product Portfolio Table 49. Thermo Fisher Scientific Recent Developments Table 50. Merck KGaA Company Information Table 51. Merck KGaA Business Overview Table 52. Merck KGaA Revenue in Anti-PD-1 MAb Business (2021-2026) & (US$ Million) Table 53. Merck KGaA Anti-PD-1 MAb Product Portfolio Table 54. Merck KGaA Recent Developments Table 55. Ximbio Company Information Table 56. Ximbio Business Overview Table 57. Ximbio Revenue in Anti-PD-1 MAb Business (2021-2026) & (US$ Million) Table 58. Ximbio Anti-PD-1 MAb Product Portfolio Table 59. Ximbio Recent Developments Table 60. Sino Biological Company Information Table 61. Sino Biological Business Overview Table 62. Sino Biological Revenue in Anti-PD-1 MAb Business (2021-2026) & (US$ Million) Table 63. Sino Biological Anti-PD-1 MAb Product Portfolio Table 64. Sino Biological Recent Developments Table 65. OriGene Technologies Company Information Table 66. OriGene Technologies Business Overview Table 67. OriGene Technologies Revenue in Anti-PD-1 MAb Business (2021-2026) & (US$ Million) Table 68. OriGene Technologies Anti-PD-1 MAb Product Portfolio Table 69. OriGene Technologies Recent Developments Table 70. Leinco Technologies Company Information Table 71. Leinco Technologies Business Overview Table 72. Leinco Technologies Revenue in Anti-PD-1 MAb Business (2021-2026) & (US$ Million) Table 73. Leinco Technologies Anti-PD-1 MAb Product Portfolio Table 74. Leinco Technologies Recent Developments Table 75. Elabscience Company Information Table 76. Elabscience Business Overview Table 77. Elabscience Revenue in Anti-PD-1 MAb Business (2021-2026) & (US$ Million) Table 78. Elabscience Anti-PD-1 MAb Product Portfolio Table 79. Elabscience Recent Developments Table 80. BioVision Company Information Table 81. BioVision Business Overview Table 82. BioVision Revenue in Anti-PD-1 MAb Business (2021-2026) & (US$ Million) Table 83. BioVision Anti-PD-1 MAb Product Portfolio Table 84. BioVision Recent Developments Table 85. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Anti-PD-1 MAb Product Image Figure 5. Global Anti-PD-1 MAb Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Anti-PD-1 MAb Market Share by Type: 2025 VS 2032 Figure 7. 1mg Product Figure 8. 2.5mg Product Figure 9. Others Product Figure 10. Global Anti-PD-1 MAb Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Anti-PD-1 MAb Market Share by Application: 2025 VS 2032 Figure 12. Pharmaceutical Product Figure 13. Research Product Figure 14. Other Product Figure 15. Global Anti-PD-1 MAb Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 16. Global Anti-PD-1 MAb Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Anti-PD-1 MAb Market Share by Region: 2025 VS 2032 Figure 18. Global Anti-PD-1 MAb Market Share by Players in 2025 Figure 19. Global Anti-PD-1 MAb Manufacturers Established Date Figure 20. Global Top 5 and 10 Anti-PD-1 MAb Players Market Share by Revenue in 2025 Figure 21. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. North America Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Anti-PD-1 MAb Market Share by Country (2021-2032) Figure 24. United States Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Canada Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Mexico Anti-PD-1 MAb Market Share by Country (2021-2032) Figure 27. Europe Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Europe Anti-PD-1 MAb Market Share by Country (2021-2032) Figure 29. Germany Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. France Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. U.K. Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. Italy Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Spain Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Russia Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Netherlands Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Nordic Countries Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Anti-PD-1 MAb Market Share by Country (2021-2032) Figure 39. China Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Japan Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. South Korea Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. India Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Anti-PD-1 MAb Market Share by Country (2021-2032) Figure 44. Australia Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. China Taiwan Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. Southeast Asia Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. South America Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Anti-PD-1 MAb Market Share by Country (2021-2032) Figure 49. Brazil Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. Argentina Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Chile Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Colombia Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Peru Anti-PD-1 MAb Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Anti-PD-1 MAb Business (2021-2026) Figure 55. Merck KGaA Revenue Growth Rate in Anti-PD-1 MAb Business (2021-2026) Figure 56. Ximbio Revenue Growth Rate in Anti-PD-1 MAb Business (2021-2026) Figure 57. Sino Biological Revenue Growth Rate in Anti-PD-1 MAb Business (2021-2026) Figure 58. OriGene Technologies Revenue Growth Rate in Anti-PD-1 MAb Business (2021-2026) Figure 59. Leinco Technologies Revenue Growth Rate in Anti-PD-1 MAb Business (2021-2026) Figure 60. Elabscience Revenue Growth Rate in Anti-PD-1 MAb Business (2021-2026) Figure 61. BioVision Revenue Growth Rate in Anti-PD-1 MAb Business (2021-2026)

Single User	$2,950 USD
Multi User	$4,430 USD
Enterprise	$5,900 USD

Anti-PD-1 MAb Industry Research Report 2026

授權報價

報告摘要

提及公司